Literature DB >> 35081362

Ligand-induced interactions between butyrophilin 2A1 and 3A1 internal domains in the HMBPP receptor complex.

Chia-Hung Christine Hsiao1, Khiem Nguyen1, Yiming Jin1, Olga Vinogradova1, Andrew J Wiemer2.   

Abstract

The ligand-bound (E)-4-hydroxy-3-methyl-but-2-enyl diphosphate (HMBPP) receptor (BTN3A1 and BTN2A1) is detectable by the T cell receptor (TCR) of Vγ9Vδ2 T cells. Although BTN3A1 binds to phosphoantigens (pAgs), the mechanisms resulting in receptor activation are not clear. We used CRISPR-Cas9, ELISA, nano-bioluminescence resonance energy transfer (BRET), and isothermal titration calorimetry (ITC) to evaluate the role of BTN2A1. Depletion of BTN2A1 and rescue experiments demonstrate that its internal domain is essential for pAg detection. Internal hetero-BRET signals are observed between BTN2A1 and BTN3A1 that are increased by pAg. ITC detects a direct interaction between the intracellular domains of BTN3A1 and BTN2A1 only in the presence of pAg. This interaction is abrogated by removal of the BTN2A1 juxtamembrane (JM) region but not by removal of the BTN3A1 JM region. Regional mutations between BTN2A1 316-326 clearly affect the interferon γ (IFNγ) response and hetero-BRET signal. Mutations to amino acids L318, W320, and L325 indicate that these amino acids are crucial. This study demonstrates a pAg-inducible interaction between BTN2A1 and BTN3A1 internal domains.
Copyright © 2022 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  BTN3A1; CD277; antigen detection; cancer immunotherapy; gamma delta T cell; glycoprotein; immune receptor; isothermal titration calorimetry; nano BRET; phosphoantigen

Mesh:

Substances:

Year:  2022        PMID: 35081362      PMCID: PMC9232852          DOI: 10.1016/j.chembiol.2022.01.004

Source DB:  PubMed          Journal:  Cell Chem Biol        ISSN: 2451-9448            Impact factor:   9.039


  34 in total

Review 1.  Illuminating insights into protein-protein interactions using bioluminescence resonance energy transfer (BRET).

Authors:  Kevin D G Pfleger; Karin A Eidne
Journal:  Nat Methods       Date:  2006-03       Impact factor: 28.547

2.  Synthesis of a phosphoantigen prodrug that potently activates Vγ9Vδ2 T-lymphocytes.

Authors:  Chia-Hung Christine Hsiao; Xiaochen Lin; Rocky J Barney; Rebekah R Shippy; Jin Li; Olga Vinogradova; David F Wiemer; Andrew J Wiemer
Journal:  Chem Biol       Date:  2014-07-24

3.  HMBPP Analog Prodrugs Bypass Energy-Dependent Uptake To Promote Efficient BTN3A1-Mediated Malignant Cell Lysis by Vγ9Vδ2 T Lymphocyte Effectors.

Authors:  Ashley M Kilcollins; Jin Li; Chia-Hung Christine Hsiao; Andrew J Wiemer
Journal:  J Immunol       Date:  2016-06-06       Impact factor: 5.422

4.  The butyrophilin 3A1 intracellular domain undergoes a conformational change involving the juxtamembrane region.

Authors:  Khiem Nguyen; Jin Li; Robbins Puthenveetil; Xiaochen Lin; Michael M Poe; Chia-Hung Christine Hsiao; Olga Vinogradova; Andrew J Wiemer
Journal:  FASEB J       Date:  2017-07-13       Impact factor: 5.191

5.  A Structural Change in Butyrophilin upon Phosphoantigen Binding Underlies Phosphoantigen-Mediated Vγ9Vδ2 T Cell Activation.

Authors:  Yunyun Yang; Liping Li; Linjie Yuan; Xiaoying Zhou; Jianxin Duan; Hongying Xiao; Ningning Cai; Shuai Han; Xianqiang Ma; Weidong Liu; Chun-Chi Chen; Lingle Wang; Xin Li; Jiahuan Chen; Ning Kang; Jing Chen; Zhixun Shen; Satish R Malwal; Wanli Liu; Yan Shi; Eric Oldfield; Rey-Ting Guo; Yonghui Zhang
Journal:  Immunity       Date:  2019-03-19       Impact factor: 31.745

6.  The Juxtamembrane Domain of Butyrophilin BTN3A1 Controls Phosphoantigen-Mediated Activation of Human Vγ9Vδ2 T Cells.

Authors:  Cassie-Marie Peigné; Alexandra Léger; Marie-Claude Gesnel; Fabienne Konczak; Daniel Olive; Marc Bonneville; Richard Breathnach; Emmanuel Scotet
Journal:  J Immunol       Date:  2017-05-01       Impact factor: 5.422

7.  Multiplex genome engineering using CRISPR/Cas systems.

Authors:  Le Cong; F Ann Ran; David Cox; Shuailiang Lin; Robert Barretto; Naomi Habib; Patrick D Hsu; Xuebing Wu; Wenyan Jiang; Luciano A Marraffini; Feng Zhang
Journal:  Science       Date:  2013-01-03       Impact factor: 47.728

8.  Vγ9Vδ2 TCR-activation by phosphorylated antigens requires butyrophilin 3 A1 (BTN3A1) and additional genes on human chromosome 6.

Authors:  Felipe Riaño; Mohindar M Karunakaran; Lisa Starick; Jianqiang Li; Claus J Scholz; Volker Kunzmann; Daniel Olive; Sabine Amslinger; Thomas Herrmann
Journal:  Eur J Immunol       Date:  2014-06-30       Impact factor: 5.532

Review 9.  Butyrophilin3A proteins and Vγ9Vδ2 T cell activation.

Authors:  Siyi Gu; Marta T Borowska; Christopher T Boughter; Erin J Adams
Journal:  Semin Cell Dev Biol       Date:  2018-03-09       Impact factor: 7.727

Review 10.  Human γδ T-Cell Control of Mucosal Immunity and Inflammation.

Authors:  Neil E McCarthy; Matthias Eberl
Journal:  Front Immunol       Date:  2018-05-07       Impact factor: 7.561

View more
  3 in total

1.  Generation of effector Vγ9Vδ2 T cells and evaluation of their response to phosphoantigen-loaded cells.

Authors:  Chia-Hung Christine Hsiao; Andrew J Wiemer
Journal:  STAR Protoc       Date:  2022-06-04

Review 2.  Butyrophilins: γδ T Cell Receptor Ligands, Immunomodulators and More.

Authors:  Thomas Herrmann; Mohindar M Karunakaran
Journal:  Front Immunol       Date:  2022-03-17       Impact factor: 7.561

Review 3.  γδ T Cells in the Tumor Microenvironment-Interactions With Other Immune Cells.

Authors:  Kok Fei Chan; Jessica Da Gama Duarte; Simone Ostrouska; Andreas Behren
Journal:  Front Immunol       Date:  2022-07-11       Impact factor: 8.786

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.